Trials / Completed
CompletedNCT01985958
A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas
A Pilot Study to Evaluate Radiotherapy-Induced Ant-Tumor Immunity in Metastatic Carcinoma of the Pancreas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: To estimate the rate at which radiotherapy to the primary or a metastatic lesion produces an immune response in patients with metastatic carcinoma of the pancreas. Secondary Objectives: To characterize the kinetics of an immune response induced by radiotherapy. To characterize the dependency of the immune response on prior exposure to chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiation therapy |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2015-09-01
- Completion
- 2019-12-01
- First posted
- 2013-11-18
- Last updated
- 2020-04-20
- Results posted
- 2019-11-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01985958. Inclusion in this directory is not an endorsement.